Fracture events in patients with primary biliary cholangitis during treatment with seladelpar in the phase III RESPONSE trial.
- DOI
- 10.1097/hc9.0000000000000845
- Published
- 2025 Dec 1
- Container
- Hepatology communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/hc9.0000000000000845,
title = {Fracture events in patients with primary biliary cholangitis during treatment with seladelpar in the phase III RESPONSE trial.},
author = {Vierling JM and Hirschfield GM and Kustra RP and Liu X and Proehl S and Crittenden DB},
year = {2025},
journal = {Hepatology communications},
doi = {10.1097/hc9.0000000000000845},
url = {https://doi.org/10.1097/hc9.0000000000000845}
}RIS
TY - JOUR TI - Fracture events in patients with primary biliary cholangitis during treatment with seladelpar in the phase III RESPONSE trial. AU - Vierling JM AU - Hirschfield GM AU - Kustra RP AU - Liu X AU - Proehl S AU - Crittenden DB PY - 2025 JO - Hepatology communications DO - 10.1097/hc9.0000000000000845 UR - https://doi.org/10.1097/hc9.0000000000000845 ER -
APA
JM, V., GM, H., RP, K., X, L., S, P., & DB, C. (2025). Fracture events in patients with primary biliary cholangitis during treatment with seladelpar in the phase III RESPONSE trial.. Hepatology communications. https://doi.org/10.1097/hc9.0000000000000845
Source records
- pubmed · retrieved 2026-09-27T00:05:13.329Z